Research Articles
Beyond Leukemia: How a Vintage Cancer Drug Is Revolutionizing Solid Tumor Treatment
Discover how L-asparaginase, a classic leukemia drug, is being repurposed to treat solid tumors through metabolic therapy and immunotherapy combinations.
The Invisible Wall: How Cultural Barriers Toppled Bluebird Bio's German Gene Therapy Dream
Analysis of how cultural differences led to Bluebird Bio's failed expansion of gene therapies in Germany despite scientific success.
The Hidden Power of Axihuitl: How a Mexican Plant Fuels the Cancer Fight
Discover how Ageratina pichinchensis, a Mexican plant, produces anti-cancer compounds through biotech innovation
The Genomic Sanctuary: How Artificial Chromosomes are Revolutionizing Stem Cell Safety
Exploring how human artificial chromosomes (HACs) are overcoming safety barriers in pluripotent stem cell therapies, with a focus on Duchenne Muscular Dystrophy treatment.
The Ancient Healer on Birch Trees: Unlocking Fomitopsis betulina's Chemical Secrets
Exploring the medicinal properties of Fomitopsis betulina, from ancient Iceman's first aid kit to modern cancer research and antibacterial applications.
The Invisible Hand in Your Medicine Cabinet: Unmasking the Medical-Industrial Complex
Exposing how the Medical-Industrial Complex prioritizes profits over patient care, with data visualizations and case studies revealing systemic issues in healthcare.
The Peach Paradox: How Red Flesh Peaches Wage War on Breast Cancer
Discover how phenolic acids in red flesh peaches selectively target and destroy breast cancer cells through molecular mechanisms.
The Alchemy of Healing: How Microbes are Supercharging Nature's Cancer Fighters
Exploring how microbial biotransformation is revolutionizing the production of plant-derived anticancer drugs through sustainable and efficient methods.
The Seaweed Revolution: Europe's Underwater Treasure Trove
Exploring Europe's seaweed revolution - from ancient food source to modern climate solution and nutritional powerhouse.
The HER2 Revolution: How a New Monoclonal Antibody is Redefining Breast Cancer Treatment
Breakthrough in breast cancer treatment with FDA approval of fam-trastuzumab deruxtecan-nxki (Enhertu) for HER2-low and HER2-ultralow metastatic breast cancer.